Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELOQ: Efmoroctocog Alfa in Hemophilia A
NCT04728217Phase 4Completed
- Sponsor
- League of Clinical Research
- Start
- Apr 2021
- Primary completion
- Feb 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of eftrenonacog alfa in hemophilia A, sponsored by League of Clinical Research. Started Apr 2021; status: completed.
02
Drugs
eftrenonacog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT04728217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04728217.